首页> 外文OA文献 >Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US)

【2h】

Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US)

机译：幼稚动物纤维素（NVAF）肥胖症患者血小露菌和华法林的比较效果及安全性（美国）（美国）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jeffrey S. Berger; François Laliberté; Akshay Kharat; Dominique Lejeune; Kenneth Todd Moore; Young Jung; Patrick Lefebvre; Veronica Ashton;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients [J] . Laliberte Francois, Cloutier Michel, Nelson Winnie W., Current medical research and opinion . 2014,第7期

机译：利伐沙班和华法林在非瓣膜性房颤患者中的现实世界比较有效性和安全性
2. Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation" [J] . Piccini Jonathan P., Hellkamp Anne S., Washam Jeffrey B., Circulation: An Official Journal of the American Heart Association . 2016,第2期

机译：Piccini等人对有关“非瓣膜性房颤患者中风的预防的中风和利伐沙班与华法林的疗效和安全性的多药”的信函的答复
3. Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation" [J] . Imprialos Konstantinos, Boutari Chrysoula, Stavropoulos Konstantinos Circulation: An Official Journal of the American Heart Association . 2016,第2期

机译：Imprialos等人关于“药学和利伐沙班与华法林在预防非瓣膜性房颤患者中风中的功效和安全性”的文章
4. Warfarin Underuse for Nonvalvular Atriai Fibrillation: How to Adjust Our Aims? [C] . G. DI PASQUALE, E. CERE, A. LOMBARDI International Workshop on Cardiac Arrhythmias . 2004

机译：Warfarin Filluse for Nonvalular Atriai颤动：如何调整我们的目标？
5. Cost effectiveness of warfarin in anticoagulant clinic after introduction of dabigatran for stroke prevention in atrial fibrillation patients in the United States [D] . Alhazami, Mai S. 2015

机译：在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
6. Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data [O] . Olivia S. Costa, Jan Beyer-Westendorf, Veronica Ashton, 2020

机译：稻草叶对肥胖非血清心房颤动患者的rivaroxaban与华法林的有效性和安全性：电子健康记录数据分析

Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US)

著录项

引文网络

相似文献

相关主题

期刊订阅